A top-10 pharma client had an urgent need to anonymize studies in a compressed timeframe for submission to the EMA. These studies contained both collection and analysis datasets and had documents containing several thousand pages. The client needed a go-to partner they could trust to handle their technical challenges within a very aggressive timeline. They came to GenInvo as an industry leader in data and document anonymization solutions AND services having a track record of successful submissions to the EMA.
The anonymized studies were delivered on time and accepted by the EMA. Having exceeded expectations, the client continues to work with GenInvo for general data transparency guidance and additional, as-needed anonymization project support.